Angus C. Russell, Director at Revance Therapeutics, Inc. (RVNC), bought 6,400 shares at $15.74 ($101K) on 2021-12-13, disclosed to the SEC on 2021-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TXMD | BUY | 2019-08-26 | $28K | — | Filing → |
| TXMD | BUY | 2019-08-15 | $99K | — | Filing → |
| BTX | BUY | 2015-11-10 | $192K | — | Filing → |